News summary produced by Claude AI
Cancer disparities researchers report significant disruptions to their work following federal funding changes that began in the prior year. According to a recent American Association for Cancer Research report, approximately 93% of surveyed researchers in this field experienced impacts from federal policy modifications. The study drew responses from 122 researchers, revealing that 78% were unable to apply for funding and 59% had ongoing research projects disrupted. Additionally, 59% of respondents indicated that lost funding originated from the National Institutes of Health.
The funding reductions were substantial in scope. Data published in JAMA Oncology in November showed that the National Cancer Institute canceled 181 grants totaling more than $317 million in roughly the first half of 2025, many of which focused on disparities. The terminations followed an executive order in January 2025 addressing what officials characterized as “radical” and “wasteful” research. While some canceled grants were later restored through court cases, subsequent terminations occurred, and new grant awards from the National Cancer Institute and National Institute of Minority Health and Health Disparities fell below historical levels for the same period in previous years.
Researchers described significant operational consequences. Some had to halt medical trials mid-treatment, disrupting patient care. Others reported workforce reductions, with some laboratories reducing staff by five to seven full-time employees or planning additional layoffs. Several researchers modified their work’s focus to comply with new restrictions, including reframing career development programs that previously targeted racial and ethnic minorities seeking entry into medicine and research fields.
The disruptions have wider implications for the field. Documented cancer disparities show that rural Americans are 18% more likely to die from cancer overall, while Black women face 35% higher mortality from breast cancer compared to white women. However, cancer disparities research has historically contributed to narrowing gaps—the disparity between Black and white cancer death rates decreased from about 34% in the 1990s to 9% currently. Researchers expressed concern that reduced funding could reverse this progress and adversely affect workforce development, as some students now hesitate to pursue academic careers in the field.